1. Home
  2. biotech

Category: Index venture

Medicxi pioneers ‘exit and reinvest’ for biotech sector with €200m close of debut secondaries fund

European life sciences investor Medicxi has hit a €200m final close for its debut secondaries fund amid using the vehicle to pick up six companies from one of the firm's previous funds.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.